FollowMyHealth Patient Portal

Maria Quintos Baggstrom, MD

Associate Professor, Medicine
Division of Oncology
Section of Medical Oncology

Specialty Areas

Lung Cancer
Medical Oncology
Thoracic Oncology
Oncology

Board Certifications

Internal Medicine
Medical Oncology

Hospital Affiliations

Barnes-Jewish West County Hospital
Barnes-Jewish Hospital

Areas of Clinical Interest

Thoracic oncology, lung cancer

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Center for Advanced Medicine
Siteman Cancer Center

4921 Parkview Place
St. Louis, MO 63110
Phone: 314-747-7222

Suite: B
Floor: 7
Office Phone: 314-747-1171
Fax: 314-362-7086

Education

Education

Fellowship: Adult Hematology/Oncology, The University of North Carolina at Chapel Hill Affiliated Hospitals, North Carolina 2002
Residency: The University of North Carolina at Chapel Hill Affiliated Hospitals, North Carolina 1999
Medical Degree: University of Texas Medical School at Houston, Texas 1996
B.A.: Williams College, Williamstown, Massachusetts 1991

Publication & Research

Publication & Research

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC.
Gerber DE, Swanson P, Lopez-Chavez A, Wong L, Dowlati A, Pennell NA, Cronier DM, Qin A, Ilaria R Jr, Cosaert J, Shahir A, Baggstrom MQ
Lung Cancer. 2017 Sep; 111108-115. doi: 10.1016/j.lungcan.2017.07.009.

PMID:
    28838379
    [PubMed - in process]
Related citations


Final Results of a Phase 3 Trial of Celecoxib (C) in Addition to Standard Chemotherapy for Advanced Non-Small Cell Lung Cancer With COX- 2 Overexpression: CALGB 30801 (Alliance).
Edelman MJ, Wang X, Hodgson L, Cheney RT, Baggstrom MQ, Sachdev T, Gajra A, Bertino EM, Reckamp KL, Molina J, Schiller J, Mitchell-Edwards K, Friedman P, Ritter J, Milne G, Stinchcombe TE, Hahn O, Vokes EE
Int J Radiat Oncol Biol Phys. 2017 May 1; 98(1)220-221. doi: 10.1016/j.ijrobp.2017.01.038.

PMID:
    28586968
    [PubMed - in process]
Related citations


Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).
Edelman MJ, Wang X, Hodgson L, Cheney RT, Baggstrom MQ, Thomas SP, Gajra A, Bertino E, Reckamp KL, Molina J, Schiller JH, Mitchell-Richards K, Friedman PN, Ritter J, Milne G, Hahn OM, Stinchcombe TE, Vokes EE, Alliance for Clinical Trials in Oncology.
J Clin Oncol. 2017 Jul 1; 35(19)2184-2192. doi: 10.1200/JCO.2016.71.3743.

PMID:
    28489511
    [PubMed - indexed for MEDLINE]
Related citations


Pulsatile Erlotinib in EGFR-Positive Non-Small-Cell Lung Cancer Patients With Leptomeningeal and Brain Metastases: Review of the Literature.
How J, Mann J, Laczniak AN, Baggstrom MQ
Clin Lung Cancer. 2017 Jul; 18(4)354-363. doi: 10.1016/j.cllc.2017.01.013.

PMID:
    28245967
    [PubMed - in process]
Related citations


Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553).
Arnold SM, Chansky K, Leggas M, Thompson MA, Villano JL, Hamm J, Sanborn RE, Weiss GJ, Chatta G, Baggstrom MQ
Invest New Drugs. 2017 Feb 16; doi: 10.1007/s10637-017-0441-4.

PMID:
    28204981
    [PubMed - as supplied by publisher]
Related citations


Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance).
Baggstrom MQ, Socinski MA, Wang XF, Gu L, Stinchcombe TE, Edelman MJ, Baker S Jr, Feliciano J, Novotny P, Hahn O, Crawford JA, Vokes EE
J Thorac Oncol. 2017 May; 12(5)843-849. doi: 10.1016/j.jtho.2017.01.022.

PMID:
    28161554
    [PubMed - in process]
Related citations


Delayed nausea and vomiting from carboplatin doublet chemotherapy.
Waqar SN, Mann J, Baggstrom MQ, Waqar MA, Chitneni P, Williams K, Gao F, Morgensztern D, Govindan R
Acta Oncol. 2016 Jun; 55(6)700-4. doi: 10.3109/0284186X.2016.1154603.

PMID:
    27145068
    [PubMed - indexed for MEDLINE]
Related citations


A Phase I Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung Cancer.
Waqar SN, Baggstrom MQ, Morgensztern D, Williams K, Rigden C, Govindan R
Chemotherapy. 2016; 61(3)144-7. doi: 10.1159/000442147.

PMID:
    26780363
    [PubMed - indexed for MEDLINE]
Related citations


Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.
Robinson CG, Patel AP, Bradley JD, DeWees T, Waqar SN, Morgensztern D, Baggstrom MQ, Govindan R, Bell JM, Guthrie TJ, Colditz GA, Crabtree TD, Kreisel D, Krupnick AS, Patterson GA, Meyers BF, Puri V
J Clin Oncol. 2015 Mar 10; 33(8)870-6. doi: 10.1200/JCO.2014.58.5380.

PMID:
    25667283
    [PubMed - indexed for MEDLINE]
Related citations


A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer.
Baggstrom MQ, Qi Y, Koczywas M, Argiris A, Johnson EA, Millward MJ, Murphy SC, Erlichman C, Rudin CM, Govindan R, Mayo Phase 2 Consortium., California Consortium.
J Thorac Oncol. 2011 Oct; 6(10)1757-60. doi: 10.1097/JTO.0b013e31822e2941.

PMID:
    21918390
    [PubMed - indexed for MEDLINE]
Related citations


Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology: focus on non-small cell lung cancer (2010).
Stinchcombe TE, Baggstrom MQ, Somaiah N, Simon GR, Govindan R
J Thorac Oncol. 2011 Jan; 6(1)227-32. doi: 10.1097/JTO.0b013e3181fd789d.

PMID:
    21178721
    [PubMed - indexed for MEDLINE]
Related citations


Barriers to enrollment in non-small cell lung cancer therapeutic clinical trials.
Baggstrom MQ, Waqar SN, Sezhiyan AK, Gilstrap E, Gao F, Morgensztern D, Govindan R
J Thorac Oncol. 2011 Jan; 6(1)98-102. doi: 10.1097/JTO.0b013e3181fb50d8.

PMID:
    21150469
    [PubMed - indexed for MEDLINE]
Related citations


Radiotherapy.
Baggstrom MQ, Govindan R
J Thorac Oncol. 2010 Dec; 5(12 Suppl 6)S476-7. doi: 10.1097/01.JTO.0000391373.71505.6c.

PMID:
    21102246
    [PubMed - indexed for MEDLINE]
Related citations


Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial.
Kim WY, Whang YE, Pruthi RS, Baggstrom MQ, Rathmell WK, Rosenman JG, Wallen EM, Goyal LK, Grigson G, Watkins C, Godley PA
Urol Oncol. 2011 Nov-Dec; 29(6)608-13. doi: 10.1016/j.urolonc.2009.09.012.

PMID:
    20022268
    [PubMed - indexed for MEDLINE]
Related citations


A phase I study of pegylated liposomal doxorubicin and irinotecan in patients with solid tumors.
Morgensztern D, Baggstrom MQ, Pillot G, Tan B, Fracasso P, Suresh R, Wildi J, Govindan R
Chemotherapy. 2009; 55(6)441-5. doi: 10.1159/000264925.

PMID:
    19996589
    [PubMed - indexed for MEDLINE]
Related citations


Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, Govindan R
J Thorac Oncol. 2010 Jan; 5(1)23-8. doi: 10.1097/JTO.0b013e3181c41e8d.

PMID:
    19934774
    [PubMed - indexed for MEDLINE]
Related citations


A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.
Govindan R, Wang X, Baggstrom MQ, Burdette-Radoux S, Hodgson L, Vokes EE, Green MR, Cancer and Leukemia Group B.
J Thorac Oncol. 2009 Feb; 4(2)220-6. doi: 10.1097/JTO.0b013e3181951eb0.

PMID:
    19179900
    [PubMed - indexed for MEDLINE]
Related citations


A phase I study of bexarotene and rosiglitazone in patients with refractory cancers.
Read WL, Baggstrom MQ, Fracasso PM, Govindan R
Chemotherapy. 2008; 54(3)236-41. doi: 10.1159/000140468.

PMID:
    18560232
    [PubMed - indexed for MEDLINE]
Related citations


A phase I study of docetaxel and bexarotene.
Wildi JD, Baggstrom MQ, Suresh R, Read W, Fracasso PM, Govindan R
Chemotherapy. 2008; 54(2)125-30. doi: 10.1159/000119706.

PMID:
    18332628
    [PubMed - indexed for MEDLINE]
Related citations


The effect of FDG-PET on the stage distribution of non-small cell lung cancer.
Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Govindan R
J Thorac Oncol. 2008 Feb; 3(2)135-9. doi: 10.1097/JTO.0b013e3181622c2c.

PMID:
    18303433
    [PubMed - indexed for MEDLINE]
Related citations

Areas of Research Interest

Cancer research